论文部分内容阅读
目前认为基因重组干扰素为治疗慢性乙型肝炎(乙肝)诸多抗病毒药物中最有希望的药物之一,现将我科应用结果报告如下。资料与方法 一、病例选择 全部病例均符合1990年全国病毒性肝炎会议(上海)制定的临床和病理诊断标准并符合下列条件者列入本组治疗对象:1.临床或病理诊断
At present, genetically modified interferon is considered as one of the most promising drugs for the treatment of many antiviral drugs for chronic hepatitis B (hepatitis B), and the results of our application are reported as follows. Data and Methods 1. All cases of case selection were in line with the clinical and pathological diagnostic criteria established by the National Viral Hepatitis Conference (Shanghai) in 1990 and were included in the treatment group according to the following criteria: 1. Clinical or pathological diagnosis